lncRNAs Play a Role in Kidney Disease
A new review highlights the critical role of lncRNAs in the development, diagnosis, and treatment of acute kidney injury (AKI) and CKD.
A new review highlights the critical role of lncRNAs in the development, diagnosis, and treatment of acute kidney injury (AKI) and CKD.
Johns Hopkins Medicine researchers report progress for accurate and easier-to-obtain markers to help predict and assess the treatment of AKI.
Healthy.io is launching a program with Boehringer Ingelheim that will support at-home testing for patients at risk of chronic kidney disease.
Acute kidney injury is common in patients in the ICU. Predicting which patients are at risk helps clinicians take preventive measures.
Read MoreResearch shows that removing a race modifier from a formula used to diagnose kidney disease may lead to equitable care for Black patients.
Read MoreMillions of COVID patients may have undiagnosed acute kidney injury, a condition where the kidneys fail to filter waste from the blood.
Read MoreResearchers established the inherited condition, TULP3-related ciliopathy, which causes kidney and liver failure in children and adults.
Read MoreIn 2010, scientists discovered that African Americans born with a certain gene have a higher risk for experiencing chronic kidney disease.
Read MoreNova Biomedical’s tool improves kidney care through improved kidney function screening and early kidney disease detection.
Read MoreSelfDecode is providing people with the opportunity to gain insight regarding their genetic predisposition for health issues.
Read MoreMetabolites in the blood whose levels are altered by coffee consumption and may contribute to risk of developing chronic kidney disease.
Read MoreGiving a big penalty to an algorithm for false negatives results in much better precision, UJ researchers find.
Read MoreThe National Kidney Foundation and the American Society of Nephrology have outlined a new race-free approach to diagnosing kidney disease.
Read MoreDespite their higher risk of chronic kidney disease, people with hypertension or diabetes usually are not given a protein in the urine test.
Read MoreRhabdomyolysis (rhabdo for short) is a sometimes fatal condition caused by overexertion that results in overtaxed muscle cells bursting and dying, releasing toxins into the body. Experts worry many people returning to the gym after a COVID-19 pandemic hiatus might push themselves too hard and wind up diagnosed with rhabdo, reports the Washington Post.
Read MoreResearchers from Boston University School of Medicine have developed a novel AI tool to predict the grade of IFTA for chronic kidney disease.
Read MoreA perspective article published in CJASN examines how the use of race in calculating kidney function, as well as other aspects of health, can cause harm to patients.
Read MoreThe NephroCheck test relies on the detection of two urinary biomarkers: TIMP-2 and IGFBP-7. Both are produced by stressed kidney cells before the onset of AKI.
Read More